https://www.valuewalk.com/2018/03/sorrento-therapeutics-srne-short/
"Circular transactions with the Nant Network"....
.....
"In the end, Sorrento PAID money[15] to the Nant network and gave it majority control of Cynviloq. We’re not sure what Sorrento received in return. Because NantWorks has no incentive to develop Cynviloq, we are skeptical that Sorrento will ever receive royalties.
In fairness, Sorrento undertook so many deals with Nant network companies in 2014-16 that we wonder whether an enterprising university might offer a degree specifically in reading the
Sorrento disclosures. Most deals were revised at least once after the initial announcement, and there was almost no information provided on what the purpose of the cooperation was or what the money would be used for. It is easy to miss things in all the announcements. But maybe that’s the point."
schöne Geschichte ? |
